Validating Billing/Encounter Codes as Indicators of Lung, Colorectal, Breast, and Prostate Cancer Re...
Validating Billing/Encounter Codes as Indicators of Lung, Colorectal, Breast, and Prostate Cancer Recurrence Using 2 Large Contemporary Cohorts
About this item
Full title
Author / Creator
Publisher
United States: by Lippincott Williams & Wilkins
Journal title
Language
English
Formats
Publication information
Publisher
United States: by Lippincott Williams & Wilkins
Subjects
More information
Scope and Contents
Contents
BACKGROUND:A substantial proportion of cancer-related mortality is attributable to recurrent, not de novo metastatic disease, yet we know relatively little about these patients. To fill this gap, investigators often use administrative codes for secondary malignant neoplasm or chemotherapy to identify recurrent cases in population-based datasets. Ho...
Alternative Titles
Full title
Validating Billing/Encounter Codes as Indicators of Lung, Colorectal, Breast, and Prostate Cancer Recurrence Using 2 Large Contemporary Cohorts
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1561979748
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1561979748
Other Identifiers
ISSN
0025-7079
E-ISSN
1537-1948
DOI
10.1097/MLR.0b013e318277eb6f
